Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion Acquisition
… Getty Images Key Facts The acquisition will give Biogen control of … eight years. The $200 million acquisition of Convergence Pharmaceuticals in 2016 … since a $6.8 billion merger with Idec in [...]
